Baseline eosinophil level may be a predictive indicator for the effectiveness of dupilumab in patients with prurigo nodularis: A single-center, real-world prospective study

被引：1
|
作者：
Yi, Xiaoqing [1 ,2 ,3 ,4 ]
Cao, Qiaozhi [1 ,2 ,3 ,4 ]
Peng, Cong [1 ,2 ,3 ,4 ]
Jia, Qiqi [1 ,2 ,3 ,4 ]
Li, Jie [1 ,2 ,3 ,4 ]
机构：
[1] Cent South Univ, Xiangya Hosp, Dept Dermatol, Changsha, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Hunan Key Lab Skin Canc & Psoriasis, Changsha, Peoples R China
[3] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha, Peoples R China
[4] Furong Lab, Changsha, Peoples R China
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2024年 / 90卷 / 05期
基金：
中国国家自然科学基金;
关键词：
adverse events; biologics; clinical efficacy; dupilumab; prurigo nodularis; real-world;
D O I：
10.1016/j.jaad.2024.01.036
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：1076 / 1078
页数：3
相关论文
共 50 条
  • [1] A real-world observational study of dupilumab treatment in adult patients with prurigo nodularis
    Zhang, Zhixin
    Li, Siyuan
    Wang, Yang
    Zhao, Jiahui
    [J]. ANAIS BRASILEIROS DE DERMATOLOGIA, 2023, 98 (04) : 440 - 448
  • [2] Dupilumab Therapy of Prurigo Nodularis: A Single-Center, Real-Life Observational Study
    Jing, Wenwen
    Yang, Danyang
    Liu, Xin
    Li, Li
    Lu, Tao
    Li, Xiaoli
    [J]. DERMATOLOGIC THERAPY, 2023, 2023
  • [3] Real-world effectiveness and drug survival of dupilumab: A single-center retrospective analysis
    Brazil, Molly
    Topham, Christina
    Simpson, Eric
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB123 - AB123
  • [4] Effectiveness of Dupilumab for Chronic Prurigo in Chinese Patients: A Real-World Case Series Study
    Lu Wei
    Mengting Yin
    Xu Yang
    Jiaying Chen
    Ruimiao Wu
    Heng Yang
    Xia Dou
    [J]. Clinical Drug Investigation, 2023, 43 : 799 - 805
  • [5] Effectiveness of Dupilumab for Chronic Prurigo in Chinese Patients: A Real-World Case Series Study
    Wei, Lu
    Yin, Mengting
    Yang, Xu
    Chen, Jiaying
    Wu, Ruimiao
    Yang, Heng
    Dou, Xia
    [J]. CLINICAL DRUG INVESTIGATION, 2023, 43 (10) : 799 - 805
  • [6] Long-term therapeutic response to dupilumab in patients affected by prurigo nodularis: A real-world retrospective study
    Chiricozzi, Andrea
    Gori, Niccolo
    Ippoliti, Elena
    Maurelli, Martina
    Antonelli, Flaminia
    Coscarella, Giulia
    Rizzo, Elisabetta
    Di Nardo, Lucia
    Girolomoni, Giampiero
    Peris, Ketty
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024,
  • [7] Dupilumab treatment in children with alopecia areata: A real-world, single-center observational study
    Shokrian, N.
    David, E.
    Del Duca, E.
    Meariman, M.
    Ghalili, S.
    Glickman, J.
    Ungar, B.
    Guttman-Yassky, E.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08) : S47 - S47
  • [8] Predictive features for effectiveness of dupilumab in elderly patients with atopic dermatitis: a real-world study
    Jia, Qiqi
    Cao, Qiaozhi
    Peng, Cong
    Shui, Xinyu
    Li, Jie
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2024,
  • [9] Laboratory markers of dupilumab patients with moderate-to-severe atopic dermatitis: a single-center, real-world study
    Hawkins, K.
    Sharma, D.
    Shokrian, N.
    Piontkowski, A.
    Ungar, B.
    Guttman-Yassky, E.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08) : S162 - S162
  • [10] Real-world effectiveness and safety of bimekizumab in Japanese patients with psoriasis: A single-center retrospective study
    Hagino, Teppei
    Saeki, Hidehisa
    Fujimoto, Eita
    Kanda, Naoko
    [J]. JOURNAL OF DERMATOLOGY, 2024, 51 (05): : 649 - 658
12345